Exact Mass: 305.0792

Exact Mass Matches: 305.0792

Found 58 metabolites which its exact mass value is equals to given mass value 305.0792, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Convicine

6-Amino-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)pyrimidine-2,4(1H,3H)-dione

C10H15N3O8 (305.0859)


Convicine is a glycoside. Convicine is a natural product found in Vicia faba and Vicia narbonensis with data available.

   

Sertraline

(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine

C17H17Cl2N (305.0738)


Sertraline is a selective serotonin uptake inhibitor that is used in the treatment of depression. Sertraline hydrochloride (also labeled under numerous brand names: Zoloft, Sertralin, Lustral, Apo-Sertral, Asentra, Gladem, Serlift, Stimuloton, Xydep, Serlain, Concorz) is an orally administered antidepressant of the selective serotonin reuptake inhibitor (SSRI) type. It was first approved by the Food and Drug Administration (FDA) in 1991. Sertraline is an odorless, white, sparingly soluble crystalline solid. The minimum effective dose is usually 50 mg per day (it can be still effective at 25 mg or 37.5 mg), but lower doses may be used in the initial weeks of treatment to acclimate the patients body, especially the liver, to the drug and to minimize the severity of any side effects. Patients who do not experience relief of symptoms at 50 mg a day may have their dose increased, up to 200 mg a day. Sertraline (HCl) is used medically mainly to treat the symptoms of depression and anxiety. It is also prescribed for the treatment of obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), premenstrual dysphoric disorder (PMDD), panic disorder (PD) and social phobia/social anxiety disorder. A study has shown that sertraline is an effective treatment for impulsive aggressive behavior in personality disordered patients. A selective serotonin uptake inhibitor that is used in the treatment of depression.; Sertraline hydrochloride (also labeled under numerous brand names: Zoloft, Sertralin, Lustral, Apo-Sertral, Asentra, Gladem, Serlift, Stimuloton, Xydep, Serlain, Concorz) is an orally administered antidepressant of the selective serotonin reuptake inhibitor (SSRI) type. It was first approved by the Food and Drug Administration (FDA) in 1991.; Sertraline is an odorless, white, sparingly soluble crystalline solid. The minimum effective dose is usually 50 mg per day (it can be still effective at 25 mg or 37.5 mg), but lower doses may be used in the initial weeks of treatment to acclimate the patients body, especially the liver, to the drug and to minimize the severity of any side effects. Patients who do not experience relief of symptoms at 50 mg a day may have their dose increased, up to 200 mg a day.; Sertraline (HCl) is used medically mainly to treat the symptoms of depression and anxiety. It is also prescribed for the treatment of obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), premenstrual dysphoric disorder (PMDD), panic disorder (PD) and social phobia/social anxiety disorder.; A study has shown that sertraline is an effective treatment for impulsive aggressive behavior in personality disordered patients. [HMDB] N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent CONFIDENCE standard compound; INTERNAL_ID 8627 CONFIDENCE standard compound; INTERNAL_ID 1500 D049990 - Membrane Transport Modulators

   

Fenoldopam

6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol

C16H16ClNO3 (305.0819)


Fenoldopam is only found in individuals that have used or taken this drug. It is a dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation. [PubChem]Fenoldopam is a rapid-acting vasodilator. It is an agonist for D1-like dopamine receptors and binds with moderate affinity to α2-adrenoceptors. It has no significant affinity for D2-like receptors, α1 and β-adrenoceptors, 5HT1 and 5HT2 receptors, or muscarinic receptors. Fenoldopam is a racemic mixture with the R-isomer responsible for the biological activity. The R-isomer has approximately 250-fold higher affinity for D1-like receptors than does the S-isomer. In non-clinical studies, fenoldopam had no agonist effect on presynaptic D2-like dopamine receptors, or α or β -adrenoceptors, nor did it affect angiotensin-converting enzyme activity. Fenoldopam may increase norepinephrine plasma concentration. C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Phenamil

3,5-Diamino-6-chloro-N-(N-phenylcarbamimidoyl)pyrazine-2-carboximidate

C12H12ClN7O (305.0792)


   

Rac-trans-Sertraline

Rac-trans-Sertraline

C17H17Cl2N (305.0738)


   

Convicine

6-amino-2-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydropyrimidin-4-one

C10H15N3O8 (305.0859)


   

7-(Diethylphosphinoyloxy)-3-cyano-4-methylcoumarin

3-Cyano-4-methyl-2-oxo-2H-chromen-7-yl diethylphosphinic acid

C15H16NO4P (305.0817)


   

Sealdin

4-(3,4-dichlorophenyl)-n-methyl-1,2,3,4-tetrahydronaphthalen-1-amine

C17H17Cl2N (305.0738)


   

dimethyl 2,6-dimethyl-4-(2-thienyl)pyridine-3,5-dicarboxylate

dimethyl 2,6-dimethyl-4-(2-thienyl)pyridine-3,5-dicarboxylate

C15H15NO4S (305.0722)


   

Maybridge3_002653

Maybridge3_002653

C13H14F3NO4 (305.0875)


   

2-(3,4-dihydro-2-hydroxy-4-oxoquinazolinyl)-1H-indole-3-carboxaldehyde|orirenierine A

2-(3,4-dihydro-2-hydroxy-4-oxoquinazolinyl)-1H-indole-3-carboxaldehyde|orirenierine A

C17H11N3O3 (305.08)


   

Wuzhuyurutine B

Wuzhuyurutine B

C17H11N3O3 (305.08)


   
   
   

fenoldopam

fenoldopam

C16H16ClNO3 (305.0819)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Sertraline

cis-sertraline

C17H17Cl2N (305.0738)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators

   

Hexose + C4H5N3O2

Hexose + C4H5N3O2

C10H15N3O8 (305.0859)


Annotation level-3

   
   

2-chloro-n-[4-(4-ethoxyphenoxy)phenyl]acetamide

2-chloro-n-[4-(4-ethoxyphenoxy)phenyl]acetamide

C16H16ClNO3 (305.0819)


   

2-amino-4-(furan-2-yl)-3-nitro-6-phenylbenzonitrile

2-amino-4-(furan-2-yl)-3-nitro-6-phenylbenzonitrile

C17H11N3O3 (305.08)


   

Toluidine Blue

toluidine blue for microscopy

C15H16ClN3S (305.0753)


D006401 - Hematologic Agents > D003029 - Coagulants > D006494 - Heparin Antagonists D006401 - Hematologic Agents > D003029 - Coagulants > D006490 - Hemostatics D004396 - Coloring Agents

   

azure b

Trimethyldiaminophenazathonium Chloride

C15H16ClN3S (305.0753)


An organic chloride salt having 3-(dimethylamino)-7-(methylamino)phenothiazin-5-ium as the counterion. It is used in making azure eosin stains for blood smear staining and is an active metabolite of methylene blue. D004396 - Coloring Agents > D001399 - Azure Stains

   

7-Chloro-1H-benzo[d]imidazole

7-Chloro-1H-benzo[d]imidazole

C14H15N3O3S (305.0834)


   

2-amino-6-(furan-2-yl)-3-nitro-4-phenylbenzonitrile

2-amino-6-(furan-2-yl)-3-nitro-4-phenylbenzonitrile

C17H11N3O3 (305.08)


   

CYCLOPENTA-2,4-DIEN-1-YLTRIMETHYLPLATINUM

CYCLOPENTA-2,4-DIEN-1-YLTRIMETHYLPLATINUM

C8H14Pt (305.0743)


   

4-(ETHYLCARBAMOYL)-3,6-DIFLUORO-[1,1-BIPHENYL]-3-CARBOXYLIC ACID

4-(ETHYLCARBAMOYL)-3,6-DIFLUORO-[1,1-BIPHENYL]-3-CARBOXYLIC ACID

C16H13F2NO3 (305.0863)


   

6-Chloro-2,3-diphenylimidazo[1,2-b]pyridazine

6-Chloro-2,3-diphenylimidazo[1,2-b]pyridazine

C18H12ClN3 (305.072)


   

Benzamide,4-methoxy-N-[(4-methylphenyl)sulfonyl]-

Benzamide,4-methoxy-N-[(4-methylphenyl)sulfonyl]-

C15H15NO4S (305.0722)


   

2-((TERT-BUTOXYCARBONYL)AMINO)-5-(TRIFLUOROMETHYL)BENZOIC ACID

2-((TERT-BUTOXYCARBONYL)AMINO)-5-(TRIFLUOROMETHYL)BENZOIC ACID

C13H14F3NO4 (305.0875)


   

1-(2-Fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamidine hydrochloride

1-(2-Fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamidine hydrochloride

C14H13ClFN5 (305.0843)


   
   

2-CHLORO-6-METHOXYISONICOTINICACID

2-CHLORO-6-METHOXYISONICOTINICACID

C13H14F3NO4 (305.0875)


   

2-[[(4-Methylphenyl)sulfonyl]amino]benzoic acid methyl ester

2-[[(4-Methylphenyl)sulfonyl]amino]benzoic acid methyl ester

C15H15NO4S (305.0722)


   

Methyl 4-amino-3-fluoro-5-nitro-2-(phenylamino)benzoate

Methyl 4-amino-3-fluoro-5-nitro-2-(phenylamino)benzoate

C14H12FN3O4 (305.0812)


   

Nicofibrate

3-Pyridinylmethyl 2-(4-chlorophenoxy)-2-methylpropanoate

C16H16ClNO3 (305.0819)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

   

[4-(2,4-difluorophenyl)-2-(methylcarbamoyl)phenyl] acetate

[4-(2,4-difluorophenyl)-2-(methylcarbamoyl)phenyl] acetate

C16H13F2NO3 (305.0863)


   

Tenofovir Monohydrate

9-[(R)-2-(Phosphonomethoxy)propyl]adenine monohydrate

C9H16N5O5P (305.0889)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Tenofovir hydrate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.

   

7-Benzyl-4-chloro-2-(methylthio)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine

7-Benzyl-4-chloro-2-(methylthio)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine

C15H16ClN3S (305.0753)


   

Benzoic acid, 4-[(6-deoxy-α-L-mannopyranosyl)amino]-, sodium salt

Benzoic acid, 4-[(6-deoxy-α-L-mannopyranosyl)amino]-, sodium salt

C13H16NNaO6 (305.0875)


   

7-Chloro-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid ethyl ester

7-Chloro-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid ethyl ester

C16H16ClNO3 (305.0819)


   

(2S)-1-(2-naphthylsulfonyl)proline

(2S)-1-(2-naphthylsulfonyl)proline

C15H15NO4S (305.0722)


   

2-METHYL-7-[3-(TRIFLUOROMETHYL)PYRIDIN-2-YL]QUINAZOLIN-4-OL

2-METHYL-7-[3-(TRIFLUOROMETHYL)PYRIDIN-2-YL]QUINAZOLIN-4-OL

C15H10F3N3O (305.0776)


   
   

ethyl 4-(benzenesulfonamido)benzoate

ethyl 4-(benzenesulfonamido)benzoate

C15H15NO4S (305.0722)


   

4-([BENZYL(METHYL)AMINO]SULFONYL)BENZOIC ACID

4-([BENZYL(METHYL)AMINO]SULFONYL)BENZOIC ACID

C15H15NO4S (305.0722)


   
   

1-(2-Fluorophenyl)-3-(4-methoxy-2-nitrophenyl)urea

1-(2-Fluorophenyl)-3-(4-methoxy-2-nitrophenyl)urea

C14H12FN3O4 (305.0812)


   

N-[2-(3-methyl-1-oxobutyl)-3-oxo-1,2,4-thiadiazol-5-yl]benzamide

N-[2-(3-methyl-1-oxobutyl)-3-oxo-1,2,4-thiadiazol-5-yl]benzamide

C14H15N3O3S (305.0834)


   

(1S,4R)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine

(1S,4R)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine

C17H17Cl2N (305.0738)


   

N-(8,9,10-Trihydroxy-7-hydroxymethyl-2,4-dioxo-6-oxa-1,3-diaza-spiro[4.5]dec-3-YL-acetamide

N-(8,9,10-Trihydroxy-7-hydroxymethyl-2,4-dioxo-6-oxa-1,3-diaza-spiro[4.5]dec-3-YL-acetamide

C10H15N3O8 (305.0859)


   

2-hydroxy-N-[(2E)-1-(5-nitro-2H-tetrazol-2-yl)propan-2-ylidene]benzohydrazide

2-hydroxy-N-[(2E)-1-(5-nitro-2H-tetrazol-2-yl)propan-2-ylidene]benzohydrazide

C11H11N7O4 (305.0872)


   

N-(4-fluorophenyl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]acetamide

N-(4-fluorophenyl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]acetamide

C14H12FN3O4 (305.0812)


   
   
   
   
   

6-Amino-5-beta-D-glucopyranosyloxyuracil

6-Amino-5-beta-D-glucopyranosyloxyuracil

C10H15N3O8 (305.0859)


   

2-[(4-amino-2,6-dihydroxypyrimidin-5-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(4-amino-2,6-dihydroxypyrimidin-5-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C10H15N3O8 (305.0859)